| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |